Sarcopenia Prevalence and Associated Factors in Male Patients with Axial Spondyloarthritis

Abstract

Background Sarcopenia is characterised by loss of muscle strength and mass, leading to falls and adverse health outcomes. Our aim was to determine the prevalence of sarcopenia in patients with axial spondyloarthritis (ax-SpA) and to identify factors associated with sarcopenia in these patients.

Methods This cross-sectional study included 120 male patients with ax-SpA and 100 healthy individuals matched for both sex and age. Sarcopenia was assessed by muscle strength, muscle mass and physical performance using the criteria determined by the Asian Working Group for Sarcopenia (AWGS). The ankylosing spondylitis disease activity score (ASDAS), laboratory indicators and bone mineral density were determined. Falls/fractures sustained over the prior year were evaluated. The association between sarcopenia and clinical characteristics was evaluated using logistic regression analyses.

Results According to the diagnostic criteria of AWGS 2019, the prevalence of sarcopenia, severe sarcopenia and possible sarcopenia was 20.8%, 9.2 and 16.7% higher than in the healthy control population (p<0.01). Factors associated with the prevalence of secondary sarcopenia in ax-SpA were ASDAS, serum levels of prealbumin and 25-(OH)D as well as the incidence of falls/fractures.

Conclusions Patients with ax-SpA have a high incidence of sarcopenia. The development of sarcopenia was associated with high ASDAS, reduced levels of prealbumin and 25-(OH)D as well as the incidence of falls/fractures.

Key words

sarcopenia - spondyloarthritis - disease activity - nutrition - osteoporosis

Schlüsselwörter

Sarkopenie - Spondyloarthritis - Krankheitsaktivität - Ernährung - Osteoporose

Publikationsverlauf

Artikel online veröffentlicht:
01. Februar 2023

• References

• 1 Cruz-Jentoft AJ, Bahat G, Bauer J. et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019; 48: 16-31
• 2 Michaud M, Balardy L, Moulis G. et al. Proinflammatory cytokines, aging, and age-related diseases. J. Am. Med. Dir. Assoc 2013; 14: 877-882
• 3 Dougados M, Baeten D. Spondyloarthritis. Lancet 2011; 377: 2127-2137
• 4 Navarro-Compán V, Sepriano A, El-Zorkany B. et al. Axial spondyloarthritis. Ann Rheum Dis 2021; 80: 1511-1521
• 5 Rudwaleit M, van der Heijde D, Landewé R. et al. The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009; 68: 777-783
• 6 Chen LK, Woo J, Assantachai P. et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc 2020; 21: 300-307
• 7 Jones G, Pilling LC, Kuo CL. Et al. Sarcopenia and Variation in the Human Leukocyte Antigen Complex. J. Gerontol. A. Biol. Sci. Med. Sci 2020; 75: 301-308
• 8 Tuttle CSL, Thang LAN, Maier AB. Markers of inflammation and their association with muscle strength and mass: a systematic review and meta-analysis. Ageing Res Rev 2020; 64: 101185
• 9 Kauppinen A, Suuronen T, Ojala J. et al. Antagonistic crosstalk between nf-κb and sirt1 in the regulation of inflammation and metabolic disorders. Cell Signal 2013; 25: 1939-1948
• 10 Bodine SC, Baehr LM. Skeletal muscle atrophy and the e3 ubiquitin ligases murf1 and mafbx/atrogin-1. Am J Physiol Endocrinol Metab 2014; 307: 469-484
• 11 Poggiali E, Migone De Amicis M, Motta I. Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases. Eur J Intern Med 2014; 25: 12-17
• 12 Santos MJ, Vinagre F, Fonseca JE. et al. Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of Caucasian female patients. Clin Exp Rheumatol 2011; 29: 470-476
• 13 Minn YK, Suk SH. Higher skeletal muscle mass may protect against is chemic stroke in community-dwelling adults without stroke and dementia: the PRESENT project. BMC Geriatr 2017; 17: 45
• 14 Hai S, Cao L, Wang H. et al. Association between sarcopenia and nutritional status and physical activity among community-dwelling Chinese adults aged 60 years and older. Geriatr Gerontol Int 2017; 17: 1959-1966
• 15 Yanai H. Nutrition for Sarcopenia. J Clin Med Res 2015; 7: 926-931
• 16 Chen Q, Hao Q, Ding Y. et al. The Association Between Sarcopenia and Prealbumin Levels Among Elderly Chinese Inpatients. J Nutr Health Aging 2018; 23: 122-127
• 17 Zhang Z, Pereira SL, Matheson EM. et al. Evaluation of Blood Biomarkers Associated with Risk of Malnutrition in Older Adults: A Systematic Review and Meta-Analysis. Nutrients 2017; 9: 829
• 18 Krajewska-Wlodarczyk M, Owczarczyk-Saczonek A, Placek W. Changes in body composition and bone mineral density in postmenopausal women with psoriatic arthritis. Reumatologia 2017; 55: 215-221
• 19 El Maghraoui A, Ebo’O FB, Sadni S. et al. Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?. BMC Musculoskelet. Disord 2016; 17: 268
• 20 Irazoqui AP, Boland RL, Buitrago CG. Actions of 1,25(OH)2-vitamin D3 on the cellular cycle depend on VDR and p38 MAPK in skeletal muscle cells. J Mol Endocrinol 2014; 53: 331-343
• 21 Mager DR, Carroll MW, Wine E. et al. Vitamin D status and risk for sarcopenia in youth with inflammatory bowel diseases. Eur J Clin Nutr 2018; 72: 623-626
• 22 Liu G, Lu L, Sun Q. et al. Poor vitamin D status is prospectively associated with greater muscle mass loss in middle-aged and elderly Chinese individuals. J Acad Nutr Diet 2014; 114: 1544-1551
• 23 Mastaglia SR, Seijo M, Muzio D. et al. Effect of vitamin D nutritional status on muscle function and strength in healthy women aged over sixty-five years. J Nutr Health Aging 2011; 15: 349-354